JPWO2021157681A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021157681A5
JPWO2021157681A5 JP2021575874A JP2021575874A JPWO2021157681A5 JP WO2021157681 A5 JPWO2021157681 A5 JP WO2021157681A5 JP 2021575874 A JP2021575874 A JP 2021575874A JP 2021575874 A JP2021575874 A JP 2021575874A JP WO2021157681 A5 JPWO2021157681 A5 JP WO2021157681A5
Authority
JP
Japan
Prior art keywords
aptamer
nucleotide
sequence represented
nucleotide sequence
ribose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021575874A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021157681A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/004215 external-priority patent/WO2021157681A1/ja
Publication of JPWO2021157681A1 publication Critical patent/JPWO2021157681A1/ja
Publication of JPWO2021157681A5 publication Critical patent/JPWO2021157681A5/ja
Pending legal-status Critical Current

Links

JP2021575874A 2020-02-06 2021-02-05 Pending JPWO2021157681A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062970842P 2020-02-06 2020-02-06
PCT/JP2021/004215 WO2021157681A1 (ja) 2020-02-06 2021-02-05 網膜下高反射病巣または網膜下高反射病巣を伴う網膜疾患の治療剤

Publications (2)

Publication Number Publication Date
JPWO2021157681A1 JPWO2021157681A1 (https=) 2021-08-12
JPWO2021157681A5 true JPWO2021157681A5 (https=) 2022-11-11

Family

ID=77199348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021575874A Pending JPWO2021157681A1 (https=) 2020-02-06 2021-02-05

Country Status (7)

Country Link
US (1) US20230065106A1 (https=)
EP (1) EP4122471A4 (https=)
JP (1) JPWO2021157681A1 (https=)
KR (1) KR20220137699A (https=)
CN (1) CN115175684A (https=)
TW (1) TWI868308B (https=)
WO (1) WO2021157681A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660985A (en) 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US20050043220A1 (en) * 2002-11-08 2005-02-24 Guyer David R. Methods and compositions for treating macular degeneration
NZ591443A (en) * 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients
EP2535410A4 (en) * 2010-02-12 2014-08-13 Ribomic Inc APTAMER FOR FGF2 AND USE THEREOF
WO2013186857A1 (ja) * 2012-06-12 2013-12-19 株式会社リボミック Ｆｇｆ２に対するアプタマー及びその使用
CA2943772C (en) * 2014-03-24 2022-07-19 Ribomic Inc. Aptamer for fgf2 and use thereof
US11123411B2 (en) * 2016-12-08 2021-09-21 Gary E. Borodic Method of treating macular degeneration using botulinum toxin-based pharmaceuticals
ES2992308T3 (es) 2018-06-29 2024-12-11 Ribomic Inc Preparación de aptámero

Similar Documents

Publication Publication Date Title
JP7625637B2 (ja) Ｂ型肝炎ウイルス感染のためのＲＮＡｉ薬
JP7792371B2 (ja) ＧａｌＮＡｃ誘導体
JP7763907B2 (ja) Ｂ型肝炎ウイルス感染のためのＲＮＡｉ薬
JP7478210B2 (ja) 修飾オリゴヌクレオチド及び使用方法
JP6752151B2 (ja) 遺伝子サイレンシングにおいて低下したｏｆｆ−ｔａｒｇｅｔ効果を有するｕｎａオリゴマー
CN108136206A (zh) 抗乙型肝炎病毒的组合物和药剂及其用途
JP2017513469A5 (https=)
JP2008531018A5 (https=)
JP2016513976A5 (https=)
CN113905744A (zh) 经修饰的间隙子寡核苷酸及其使用方法
JP2020526192A5 (https=)
JP2021515784A5 (https=)
JP2021515784A (ja) 修飾オリゴヌクレオチド及びタウオパチーにおける使用方法
US20170009230A1 (en) Compositions for inhibiting dux4 gene expression and uses thereof
JP2011515357A5 (https=)
JP2021524277A (ja) Ｒｔｅｌ１発現の調節用のオリゴヌクレオチド
JP2020521491A5 (https=)
JPWO2021157681A5 (https=)
WO2010008474A4 (en) Methods for treating multiple sclerosis using antisense oligonucleotides
US20250066793A1 (en) Anti-sense oligonucleotides and uses thereof
CN114057816B (zh) 富含腺嘌呤硫代磷酸酯化寡核苷酸及其抗肝炎病毒的应用
CN112840026B (zh) 抑制tigit基因表达的组合物和方法
RU2802836C2 (ru) Модифицированные олигонуклеотиды и способы их применения
JP3868021B2 (ja) ヒトインターロイキン−６レセプター発現阻害剤
HK40036011A (en) Galnac derivatives